- BlueCity Holdings Limited (“BlueCity” or the “Company”) (NASDAQ:BLCT), a leading online LGBTQ platform, today announced that its Board of Directors (the “Board”) has received a
BlueCity Holdings (NASDAQ:BLCT) reported $38.20 million in sales this quarter. This is a 10.60 percent decrease over sales of $42.73 million the same period last year.
Gainers
Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.
Gainers
Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer.
BlueCity Holdings Limited ( "BlueCity" or the "Company") (NASDAQ: BLCT), a leading online LGBTQ platform, today announced that its board of directors (the "Board") has received a preliminary non-binding proposal letter (the "Proposal Letter"), dated January 2, 2022, from Mr.